Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Establishment of Reference Reagents for Single-Radial-Immunodiffusion Assay on the 2022/23 Seasonal Influenza Vaccine in Japan and Their Quality Validation.
Shimasaki N, Kuwahara T, Nishijima H, Nakamura K, Sato K, Murano K, Itamura S, Akahori Y, Takashita E, Kishida N, Arita T, Nakauchi M, Takeda M, Hasegawa H, Ryo A, Harada Y. Shimasaki N, et al. Among authors: itamura s. Jpn J Infect Dis. 2024 Mar 21;77(2):105-111. doi: 10.7883/yoken.JJID.2023.218. Epub 2023 Nov 30. Jpn J Infect Dis. 2024. PMID: 38030271 Free article.
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
Asahi-Ozaki Y, Itamura S, Ichinohe T, Strong P, Tamura S, Takahashi H, Sawa H, Moriyama M, Tashiro M, Sata T, Kurata T, Hasegawa H. Asahi-Ozaki Y, et al. Among authors: itamura s. Microbes Infect. 2006 Oct;8(12-13):2706-14. doi: 10.1016/j.micinf.2006.07.018. Epub 2006 Aug 28. Microbes Infect. 2006. PMID: 16968669 Free article.
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.
Ichinohe T, Kawaguchi A, Tamura S, Takahashi H, Sawa H, Ninomiya A, Imai M, Itamura S, Odagiri T, Tashiro M, Chiba J, Sata T, Kurata T, Hasegawa H. Ichinohe T, et al. Among authors: itamura s. Microbes Infect. 2007 Sep;9(11):1333-40. doi: 10.1016/j.micinf.2007.06.007. Epub 2007 Jul 1. Microbes Infect. 2007. PMID: 17890128 Free article.
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
Ichinohe T, Tamura S, Kawaguchi A, Ninomiya A, Imai M, Itamura S, Odagiri T, Tashiro M, Takahashi H, Sawa H, Mitchell WM, Strayer DR, Carter WA, Chiba J, Kurata T, Sata T, Hasegawa H. Ichinohe T, et al. Among authors: itamura s. J Infect Dis. 2007 Nov 1;196(9):1313-20. doi: 10.1086/521304. Epub 2007 Oct 5. J Infect Dis. 2007. PMID: 17922395 Free PMC article.
Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus.
Ohnishi K, Takahashi Y, Kono N, Nakajima N, Mizukoshi F, Misawa S, Yamamoto T, Mitsuki YY, Fu S, Hirayama N, Ohshima M, Ato M, Kageyama T, Odagiri T, Tashiro M, Kobayashi K, Itamura S, Tsunetsugu-Yokota Y. Ohnishi K, et al. Among authors: itamura s. Jpn J Infect Dis. 2012;65(1):19-27. Jpn J Infect Dis. 2012. PMID: 22274153 Free article.
83 results